The first MCL-1-selective BH3 mimetics have therapeutic potential for chronic lymphocytic leukemia. [electronic resource]
Producer: 20161107Description: 32-6 p. digitalISSN:- 1879-0461
- Aniline Compounds -- pharmacology
- Antineoplastic Agents -- pharmacology
- Bridged Bicyclo Compounds, Heterocyclic -- pharmacology
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Myeloid Cell Leukemia Sequence 1 Protein -- antagonists & inhibitors
- Peptide Fragments -- analysis
- Proto-Oncogene Proteins -- analysis
- Sulfonamides -- pharmacology
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.